Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

Febrile illness in high-risk children: a prospective, international observational study.

Journal article

van der Velden FJS. et al, (2022), European journal of pediatrics

Detection of poliovirus in London highlights the value of sewage surveillance.

Journal article

Hill M. and Pollard AJ., (2022), Lancet (London, England)

Effect of the of 10-valent pneumococcal conjugate vaccine in Nepal 4 years after introduction: an observational cohort study

Journal article

Shrestha S. et al, (2022), The Lancet Global Health, 10, e1494 - e1504

Variation in CFHR3 determines susceptibility to meningococcal disease by controlling factor H concentrations.

Journal article

Kumar V. et al, (2022), American journal of human genetics

Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme.

Journal article

Carr JP. et al, (2022), Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Addressing vaccine inequities among Ukrainian refugees.

Journal article

Hill M. et al, (2022), Lancet Infect Dis, 22, 935 - 936

An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females

Journal article

Marchevsky NG. et al, (2022), eBioMedicine, 81, 104128 - 104128

Year-to-year variation in attack rates could result in underpowered respiratory syncytial virus vaccine efficacy trials

Journal article

Billard MN. et al, (2022), Journal of Clinical Epidemiology, 147, 11 - 20

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees.

Journal article

Nutalai R. et al, (2022), Cell, 185, 2116 - 2131.e18

Load More